Skip to main content

Want a detailed portfolio tracker?

Day One Biopharmaceuticals (DAWN) P/E (2021 - 2026)

Day One Biopharmaceuticals (DAWN) P/E from Jun 30, 2021 to Apr 23, 2026. The TTM Day One Biopharmaceuticals (DAWN) P/E is -20.50. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Day One Biopharmaceuticals (DAWN)

YearP/EChange
2026-20.50+131.01%
2025-8.88-26.65%
2024-12.10+80.67%
2023-6.70-43.09%
2022-11.77-35.08%
2021-18.13N/A

Comparison Day One Biopharmaceuticals (DAWN) P/E with competitors

Day One Biopharmaceuticals (DAWN) P/E is -20.50.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.02%
ENLVEnlivex Ltd0.07-100.36%
FGENFibroGen Inc0.24-101.17%
CHRSCoherus Biosciences Inc0.85-104.14%
FBIOFortress Biotech Inc0.95-104.63%
ORMPOramed Pharmaceuticals Inc1.50-107.33%
AGENAgenus Inc3.01-114.68%
INVAInnoviva Inc3.15-115.38%
VXRTVaxart Inc3.55-117.31%
CRMDCorMedix Inc3.63-117.69%
CVACCureVac N.V.4.45-121.68%
GLPGGalapagos NV4.86-123.70%
SRPTSarepta Therapeutics Inc4.88-123.81%
ABEOAbeona Therapeutics Inc5.39-126.27%
ABUSArbutus Biopharma Corp5.60-127.29%
ZVRAZevra Therapeutics Inc5.89-128.71%
SPROSpero Therapeutics Inc6.23-130.37%
CGENCompugen Ltd6.31-130.79%
RIGLRigel Pharmaceuticals6.87-133.51%
SLXNSilexion Therapeutics Corp7.30-135.58%
OMEROmeros Corporation9.26-145.15%
AUPHAurinia Pharmaceuticals Inc9.58-146.74%
PLXProtalix BioTherapeutics Inc10.89-153.11%
ACADAcadia Pharmaceuticals Inc11.73-157.20%
TBPHTheravance Biopharma Inc12.26-159.80%
ADMAAdma Biologics Inc12.42-160.56%
HRMYHarmony Biosciences Holdings Inc13.82-167.40%
SABSSAB Biotherapeutics Inc14.14-168.94%
NAGENiagen Bioscience Inc14.82-172.26%
INCYIncyte Corp15.82-177.16%
REGNRegeneron Pharmaceuticals Inc15.86-177.33%
PBYIPuma Biotechnology Inc17.32-184.44%
CPRXCatalyst Pharmaceuticals Inc17.44-185.05%
EXELExelixis Inc17.54-185.53%
TGTXTG Therapeutics Inc18.97-192.49%
MDXGMimedx Group Inc20.55-200.23%
XOMAXOMA Royalty Corp22.87-211.56%
ARGXArgen X SE24.30-218.50%
CTMXCytomX Therapeutics Inc24.82-221.05%
XOMAOXOMA Royalty Corp25.34-223.60%
HALOHalozyme Therapeutics Inc25.62-224.96%
XOMAPXOMA Royalty Corp25.67-225.19%
VRTXVertex Pharmaceuticals Inc27.99-236.53%
RPRXRoyalty Pharma plc - Class A28.69-239.90%
SLNOSoleno Therapeutics Inc29.02-241.50%
ASNDAscendis Pharma A/S30.09-246.72%
LGNDLigand Pharmaceuticals Inc - Class B37.91-284.89%
APLSApellis Pharmaceuticals Inc39.02-290.30%
BMRNBiomarin Pharmaceutical Inc42.21-305.86%
KRYSKrystal Biotech Inc45.34-321.13%
ONCBeiGene Ltd69.54-439.14%
PHARPharming Group N.V.75.03-465.89%
TECHBio-Techne Corp101.96-597.23%
VCELVericel Corp109.92-636.07%
ALNYAlnylam Pharmaceuticals Inc117.96-675.30%
GMABGenmab140.29-784.17%
TLXTelix Pharmaceuticals Ltd162.15-890.79%
CORTCorcept Therapeutics Inc212.86-1138.07%